Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Validation of the 2017 Weighted criteria compared to the 1997 ACR and the 2012 SLICC in Pediatric Systemic Lupus Erythematosus.

Ma M, Hui-Yuen JS, Cerise JE, Iqbal S, Eberhard BA.

Arthritis Care Res (Hoboken). 2019 Sep 3. doi: 10.1002/acr.24057. [Epub ahead of print]

PMID:
31478595
2.

Integrative analysis of rare copy number variants and gene expression data in alopecia areata implicates an aetiological role for autophagy.

Petukhova L, Patel AV, Rigo RK, Bian L, Verbitsky M, Sanna-Cherchi S, Erjavec SO, Abdelaziz AR, Cerise JE, Jabbari A, Christiano AM.

Exp Dermatol. 2019 Jun 6. doi: 10.1111/exd.13986. [Epub ahead of print]

PMID:
31169925
3.

Application of t-SNE to human genetic data.

Li W, Cerise JE, Yang Y, Han H.

J Bioinform Comput Biol. 2017 Aug;15(4):1750017. doi: 10.1142/S0219720017500172. Epub 2017 Jun 23.

PMID:
28718343
4.

Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata.

Mackay-Wiggan J, Jabbari A, Nguyen N, Cerise JE, Clark C, Ulerio G, Furniss M, Vaughan R, Christiano AM, Clynes R.

JCI Insight. 2016 Sep 22;1(15):e89790. doi: 10.1172/jci.insight.89790.

5.

Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata.

Kennedy Crispin M, Ko JM, Craiglow BG, Li S, Shankar G, Urban JR, Chen JC, Cerise JE, Jabbari A, Winge MC, Marinkovich MP, Christiano AM, Oro AE, King BA.

JCI Insight. 2016 Sep 22;1(15):e89776. doi: 10.1172/jci.insight.89776.

6.

Molecular signatures define alopecia areata subtypes and transcriptional biomarkers.

Jabbari A, Cerise JE, Chen JC, Mackay-Wiggan J, Duvic M, Price V, Hordinsky M, Norris D, Clynes R, Christiano AM.

EBioMedicine. 2016 May;7:240-7. doi: 10.1016/j.ebiom.2016.03.036. Epub 2016 Mar 31.

7.

Treatment of an alopecia areata patient with tofacitinib results in regrowth of hair and changes in serum and skin biomarkers.

Jabbari A, Nguyen N, Cerise JE, Ulerio G, de Jong A, Clynes R, Christiano AM, Mackay-Wiggan J.

Exp Dermatol. 2016 Aug;25(8):642-3. doi: 10.1111/exd.13060. No abstract available.

8.

Master regulators of infiltrate recruitment in autoimmune disease identified through network-based molecular deconvolution.

Chen JC, Cerise JE, Jabbari A, Clynes R, Christiano AM.

Cell Syst. 2015 Nov 25;1(5):326-337.

9.

Pharmacologic inhibition of JAK-STAT signaling promotes hair growth.

Harel S, Higgins CA, Cerise JE, Dai Z, Chen JC, Clynes R, Christiano AM.

Sci Adv. 2015 Oct 23;1(9):e1500973. doi: 10.1126/sciadv.1500973. eCollection 2015 Oct.

10.

Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib.

Jabbari A, Dai Z, Xing L, Cerise JE, Ramot Y, Berkun Y, Sanchez GA, Goldbach-Mansky R, Christiano AM, Clynes R, Zlotogorski A.

EBioMedicine. 2015 Feb 26;2(4):351-5. doi: 10.1016/j.ebiom.2015.02.015. eCollection 2015 Apr.

11.

Induced pluripotent stem cells from human revertant keratinocytes for the treatment of epidermolysis bullosa.

Umegaki-Arao N, Pasmooij AM, Itoh M, Cerise JE, Guo Z, Levy B, GostyƄski A, Rothman LR, Jonkman MF, Christiano AM.

Sci Transl Med. 2014 Nov 26;6(264):264ra164. doi: 10.1126/scitranslmed.3009342.

12.

Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition.

Xing L, Dai Z, Jabbari A, Cerise JE, Higgins CA, Gong W, de Jong A, Harel S, DeStefano GM, Rothman L, Singh P, Petukhova L, Mackay-Wiggan J, Christiano AM, Clynes R.

Nat Med. 2014 Sep;20(9):1043-9. doi: 10.1038/nm.3645. Epub 2014 Aug 17.

13.

Microenvironmental reprogramming by three-dimensional culture enables dermal papilla cells to induce de novo human hair-follicle growth.

Higgins CA, Chen JC, Cerise JE, Jahoda CA, Christiano AM.

Proc Natl Acad Sci U S A. 2013 Dec 3;110(49):19679-88. doi: 10.1073/pnas.1309970110. Epub 2013 Oct 21.

14.

Principal components ancestry adjustment for Genetic Analysis Workshop 17 data.

Jin J, Cerise JE, Kang SJ, Yoon EJ, Yoon S, Mendell NR, Finch SJ.

BMC Proc. 2011 Nov 29;5 Suppl 9:S66. doi: 10.1186/1753-6561-5-S9-S66.

Supplemental Content

Loading ...
Support Center